RHTP GRANT SUBMISSION HELP CENTER
The $50B Rural Health Transformation Program
could fund a new diabetic eye screening program
RHTP's $50B supports rural health modernization, including infrastructure, technology, and preventive care, across several approved funding categories. Diabetic retinopathy screening fits two of them: Chronic Disease Management and Technology Innovation. Grants could cover subscription costs for autonomous AI diabetic eye exams, while CPT reimbursement adds recurring revenue.
FDA-cleared Autonomous AI
Supports Epic & Major EHRs
CPT 92229 Reimbursement
What is RHTP?
$50B
DISTRIBUTED TO ALL 50 STATES, 2026-2030
The Rural Health Transformation Program is a federal fund distributed to every state over five years. Every state must fund at least three approved categories, two show up again and again:
Chronic Disease Prevention & Managemen
Technology Innovation
Why this matters for diabetic eye screening
Chronic disease management is an explicitly approved funding category.
Technology innovation is a primary, pre-approved focus area.
Several state plans already explicitly reference diabetes care and AI-enabled diagnostics as high-priority health equity metrics.
Eligible clinics can use funding to offset autonomous diabetic eye screening costs, closing care gaps while generating revenue.
Is your state already moving? Check out the NRHA 50-state tracker →
AEYE-DS: FDA-Cleared Autonomous AI Designed for Primary Care
AEYE-DS is an FDA-cleared autonomous AI solution that screens and diagnoses for diabetic retinopathy in 1 minute during the visit using a portable handheld camera.
→
EHR Alert
​
Open care gap flagged automatically
.png)
→
Image capture
​
1 image per eye, no dilation captured with a portable camera
→
Instant AI diagnosis
​
Results discussed in-visit; referral triggered for positive cases
→
Close care gap & reimbursement
HEDIS EED + CPT 92229 through EHR automation
→
→
→
1 minute screening. Run by your staff. EHR intergrated.
Why clinics are funding AEYE-DS through RHTP
Over 60% of diabetic patients miss their annual eye exam, and rural specialists are scarce, distant, and booked out for months. 95% of severe vision loss can be prevented with early detection and treatment, with >99% imageability AEYE-DS screens virtually every patient in-visit. RHTP can offset your subscription, plus CPT 92229 reimbursement per exam.
→
RHTP grant
​
Funds the technology, subscription for a 1-minute screening, run by your staff.
​
→
CPT 92229 billing
​
Reimbursement for every screening,
~$50 per exam nationally.
→
Ongoing revenue & quality impact
Supporting HEDIS Diabetes Eye Exam measure and MIPS Quality Measure 117.
.png)
→
Better patient outcomes
Patients get screened in-visit, results discussed on the spot, care gap closed
+
=
→
The grant funds the technology. Reimbursement pays for every exam after that.
Two separate things, so instead of competing, they compound.
We Support Your Application: Your Complimentary State Grant Kit
State eligibility review
Formal quote
Paste-ready sustainability language
Letter of support
Budget narrative mapped to your state's requirementsview
Find your state's deadline: NRHA 50-state tracker →
Frequently asked questions
Book a time to get your free RHTP grant support pack
RHTP is a competitive, scored, state-administered program; funding approval is not guaranteed and no state has named AEYE-DS by product. This overview reflects public program data as of mid-2026. Confirm active application deadlines directly with your state RHTP office before submitting. All public program data is updated as of mid-2026.